Raymond J. Andersen
Corporate Officer/Principal at University of British Columbia
Profile
Raymond J.
Andersen is the founder of Aquinox Pharmaceuticals, Inc. (founded in 2003) and ESSA Pharma, Inc. (founded in 2009).
At ESSA Pharma, he held the titles of Secretary, Director & Chief Technical Officer from 2010 to 2019.
Currently, he is a Professor at the University of British Columbia, a position he has held since 1977.
Dr. Andersen's education includes an undergraduate degree from the University of Alberta, a graduate degree from the University of California, Berkeley, and a doctorate from the University of California San Diego.
Raymond J. Andersen active positions
| Companies | Position | Start |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | 01/01/1977 |
Former positions of Raymond J. Andersen
| Companies | Position | End |
|---|---|---|
| ESSA PHARMA INC. | Founder | 31/07/2019 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Founder | - |
Training of Raymond J. Andersen
| University of Alberta | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| Private companies | 1 |
|---|---|
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Raymond J. Andersen
